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25% normal). The b r a i n had very low enzyme l e v e l s (12% normal). Conclusion: BMT o f f e r s t h e Gaucher p a t i e n t e f f e c t i v e enzyme r eplacement f o r c e l l s of marrow o r i g i n i n t h e c i r c u l a t i o n and i n r e t i c u l o e n d o t h e l i a l organs. Whether remissions of c l i n i c a l d i se a s e w i l l occur and glc-ase l e v e l s i n t h e CNS w i l l r i s e a f t e r BMT remains t o he determined. hrs. Bilirubin binding studies including reserve bilirubin binding capacity (RBBC), and saturation index (SI) were performed using a bilirubin fluorometer.
BILIRUBIN ALBUMIN BINDING (BAB) ASSAY IN
No significant changes pre, on, or post ECMO were noted on the hemoglobin and fibrinogen levels. The bilirubin levels were not significantly different pre and on ECMO and were lower post ECMO. As shown in the table, there were significant changes pre, on, and post ECMO plasma hemoglobin values. Significant changes between pre and on ECMO values only were noted on the infant's platelet, fibrin split products and SGOT levels. Thus, t h e hemolysis that occurs during ECMO does not adversely effect t h e RBBC and SI from any alterations in the High-dose IV IgG therapy may cause a r a p i d increment i n p l a t el e t counts i n c h i l d r e n with immune thrombocytopenia. We have evaluated t h i s t h e r a p e u t i c approach i n t h r e e c h i l d r e n (2F, 1M: ages 10,22 and 30 mos.) with neutropenia and a b s o l u t e n e u t r o p h i l counts (ANC's) <500/ul. P a t i e n t s were given 1 G/Kg of Sandog l o b u l i n i n t r a v e n o u s l y on each of two consecutive days. Two c h i l d r e n had c l e a r evidence of autoimmune neutropenia a s evidenced by: a ) +ve c i r c u l a t i n g n e u t r o p h i l antibody (NAb): and b) normal i n -v i t r o g r a n u l o p o i e s i s (CFU-C) which was i n h i b i t e d (50%( ) by autologous serum. Both c h i l d r e n had r a p i d responses t o IV IgG therapy with ANC's i n c r e a s i n g from 220 and 3601111 pre-therapy t o 3110 and 5 3 6 0 1~1 48 h r s . post-therapy.
Responses were maintained f o r 2 t o 3 weeks. I n one c h i l d impaired c l e a r a n c e of autologous, anti-D coated, 9 y m~c -t a g g e d red blood c e l l s confirmed r e t i c u l oe n d o t h e l i a l c e l l blockade a s t h e mechanism of a c t i o n of IV IgG. As a c o n t r o l we t r e a t e d one c h i l d w i t h an i n h e r i t e d (autosomal dominant) neutropenia. No response t o IV IgG occurred. I n t h i s c h i l d neutropenia was due t o impaired g r a n u l o p o i e s i s w i t h in-vivo and i n -v i t r o growth a r r e s t a t t h e myelocyte s t a g e . Autologous s e r a had no e f f e c t on i n -v i t r o c e l l growth (CFU-C) a n d c i r c u l a t i n g NAb's were not p r e s e n t . These r e s u l t s s u g g e s t t h a t high-dose IV IgG i s a u s e f u l t h e r a p e u t i c o p t i o n i n p a t i e n t s with immunemediated neutropenia; i n -v i t r o s t u d i e s of hematopoiesis and a s e a r c h f o r c i r c u l a t i n g NAb's may p r e d i c t those p a t i e n t s most l i k e l y t o respond t o t h i s t h e r a p e u t i c i n t e r v e n t i o n . of Colorado Health Sciences C e n t e r , Denver, CO. Neutropenia, d e f i n e d a s an a b s o l u t e n e u t r o p h i l count 11000, o c c u r s f r e q u e n t l y i n t h e g e n e r a l p e d i a t r i c p o p u l a t i o n . I t s incidence and a s s o c i a t i o n with i n f e c t i o n , b o t h s e l f -l i m i t e d and more s e r i o u s , have n o t been w e l l d e s c r i b e d .
A r e t r o s p e c t i v e review o f 1198 i n p a t i e n t s and 215 outp a t i e n t s was performed t o determine t h e i n c i d e n c e . Three p e r c e n t o f i n p a t i e n t s were found t o have neutropenia. Howe v e r , 80% of t h e c h i l d r e n p r e s e n t i n g w i t h neutropenia were without s i g n s o r symptoms of i n f e c t i o n . Three c h i l d r e n had a s s o c i a t e d v i r a l symptoms, 1 had a documented b a c t e r i a l mening i t i s and 2 had a combination of v i r a l and b a c t e r i a l i n f e c t i o n . The l a r g e s t s i n g l e d i a g n o s i s a s s o c i a t e d with neutropenia was s e r o u s o t i t i s media (SOM), accounting f o r 35% o f neutropenia i n p a t i e n t s . While making up only 35% of t o t a l admissions, 7.5% o f a l l p a t i e n t s with t h e d i a g n o s i s of SOM had neutropenia.
Of 215 o u t p a t i e n t s reviewed, 7% were neutropenic. A s w i t h t h e i n p a t i e n t group, a m a j o r i t y of c h i l d r e n w i t h neutropenia were without s i g n s and symptoms of i n f e c t i o n .
Neutropenia appears t o be a common i n c i d e n t a l f i n d i n g i n otherwise h e a l t h y c h i l d r e n . I n o u r study. i t was most commonly s e e n w i t h s e r o u s o t i t i s media. We conclude t h a t neutropenia r e p r e s e n t e d by t h e p a t i e n t s reviewed h e r e i s most l i k e l y s h o r tl i v e d , t r a n s i e n t i n n a t u r e , and needs no s p e c i a l e v a l u a t i o n o r a l t e r e d t r e a t m e n t p l a n , u n l e s s p e r s i s t e n t o r r e c u r r e n t . 
PLATELET ASSOCIATED IMMUNE GLOBULIN(PAI~)IN THE

COURSE OF C H I L D H O O D I D IOPATH
P l a t e l e t a s s o c i a t e d immune globulin'was s t b d i e d during the course o f ITP in 15 c h i l d r e n ; t h e m i c r o t i t e r s o l i d phase immunoassay was used.Values in 10 p a t i e n t s with a c u t e ITP were compared with those in 5 c h i l d r e n with chronic ITP.
At the onset,PAlgG was e l e v a t e d in 9/10 c h i l d r e n with a c u t e I T P ;~/~O had leveIs>70fg/pl (median PAlgG=91 .7;normal=<5.2fg/pl) The one c h i l d with a c u t e ITP whose PAlgG was normal recovered w i t h i n two weeks.At recovery PAlgG l e v e l s had f a l l e n below IOfg/pl(median 3.7 f g / p l ) in 7/8;5/7 had normal l e v e l s .
In c o n t r a s t , 4/5 c h i l d r e n whose d i s e a s e became c h r o n i c , had lower l e v e l s of PAlgG (<16.7fg/p1).0nly 1/5 chronic ITP p a t i e n t s had markedly e l e v a t e d PA1gG.ln 2 p a t i e n t s post-splenectorny, l e v e l s were normal even in t r a n s i e n t periods of thrombocytopenia In one patient,PAlgG rose d r a m a t i c a l l y t o 75 fg/pl during an i n t e r c u r r e n t v i r a l i l l n e s s . Another p a t i e n t ' s PAlgG l e v e l s rose t r a n s i e n t l y following treatment with I V gamma g l o b u l i n ; no change in t h e p l a t e l e t count occurred. These f i n d i n g s suggest t h a t PAlgG i s u s u a l l y higher a t t h e o n s e t o f c l a s s i c childhood ITP ( a c u t e ) than in those c h i l d r e n whose course becomes chronic although the l e v e l s a r e not i n d i v i d u a l l y p r e d i c t i v e . The observed drop in PAlgG a f t e r splenectomy a s well a s t h e sharp r i s e s noted during i n f e c t i o n and gammaglobulin treatment deserve f u r t h e r study t o help understand t h e r e l a t i o n s h i p between thrornbocytopenia and PAIgG. The r e t i c u l o e n d o t h e l i a l (RE). phagocytic f u n c t i o n o f t h e spleen i s a major mechanism o f defense a q a i n s t i n v a s i v e i n f e c t i o n s due t o S: {n,eumoniae and H. influenza;, two organisms which o f t e n a f f e c t c 1 dren wlth cancer. L i t t l e information i s a v a i l a b l e about t h e e f f e c t s of malianancv and of c v t n t o x i c -, -----a g e n t s on phagocytic f u n c t i o n . he ref ope, s t u d i e d s p l e n i c RE f u n c t i o n i n c h i l d r e n with cancer r e c e i v i n g d i v e r s e forms of chemotherapy by q u a n t i t a t i o n of p i t t e d o r pocked e r y t h r o c y t e s ( p i t c o u n t s ) . The p i t count (PC) i s t h e percentage o f e r y t h r o c y t e s c o n t a i n i n g one o r more membrane-bound v e s i c l e s a s determined by i n t e r f e r e n c e phase microscopy. The mean PC i n 77 normal c h i l d r e n and a d u l t s was 0.53% (range 0-2.0%), with only 2.6% of normal s u b j e c t s having values over 1.5%. Mean PC in 28 splenectomized s u b j e c t s was 37% (range 3.2-81%). Among 158 c h i l d r e n with cancer (361 specimens), t h e mean PC was 1.10% (range 0-12.6%). Forty-six p a t i e n t s (30%) had one o r more values above 1.5%, and 16 c h i l d r e n (11%) had PC measurements above 3.0%, a l e v e l previously suggested t o have c l i n i c a l s i g n i f i c a n c e . Elevated PC ( > 1.5%) occurred in over 1/3 of c h i l d r e n with Wilms' tumor and ALL and appeared t o be r e l a t e d t o chemotherapy r a t h e r than t o t h e malignancy i t s e l f . Mild s p l e n i c RE hypofunction occurs i n many c h i l d r e n with c a n c e r , probably r e s u l t s from chemotherapy, and may c o n t r i b u t e t o t h e risk of s e r i o u s i n f e c t i o n during treatment with c y t o t o x i c a g e n t s .
